Civil Defense Perspectives January 2024 (vol. 39 #1)
The finding of DNA fragments in COVID-19 mRNA vaccines, by standard laboratory methods by professional researchers, has created a great stir. It is actual affirmative evidence of potential danger—but only a first step (tinyurl.com/3af6xf3t). The scientists, principally Kevin McKernan and Phillip Buckhaults, Ph.D., carefully divulged the limitations of their work, including the small number of vaccine samples and lack of a chain of custody, and emphasized the need for further research.
The reports do not come from the Ivy League or from eminent scientists or from NEJM. Dr. Buckhaults has not yet published his findings, but provided oral testimony before the South Carolina Senate. McKernan, who has an undergraduate degree in biology, is the founder of Medicinal Genomics, a company that markets test kits and genomics-related services to the cannabis, hemp, and mushroom industries (tinyurl.com/3ns3ywny). Dr. Buckhaults is a professor in the College of Pharmacy at the University of South Carolina.
The work is under attack, and the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) deny that the “small” quantities of DNA fragments are a problem. The FDA sets a regulatory threshold for residual DNA, and the tested samples reportedly exceeded this. An EMA spokesperson said the agency was not “aware of scientific evidence showing that the…residual DNA that may be present in vaccine batches could integrate into the DNA of vaccinated individuals” (ibid.). And “there isn’t evidence to date that the vaccines cause cancer or have led to an increase in cancer” (ibid.).
Continue reading “Beyond Negative Evidence on COVID Vaccines”